In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 0 a new company low.

Within Major Pharmaceutical Preparations industry 436 other companies have achieved higher Quick Ratio than Cnbx Pharmaceuticals Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 110 to 4209.

Explain Quick Ratio?
How much Cash & cash equivalents CNBK�s has?
What are CNBK�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CNBK Quick Ratio	(May 31 2026) Q3	(Feb 28 2026) Q2	(Nov 30 2025) Q1	(Aug 31 2025) Q4	(May 31 2025) Q3
Y / Y Current Liabilities Change	93.47 %	74.34 %	87.22 %	-96.31 %	-6.89 %
Y / Y Cash & cash equivalent Change	-30.39 %	-73.39 %	-55.57 %	-42.8 %	-81.41 %
Quick Ratio MRQ	0	0	0	0.31	0.01
CNBK's Total Ranking	# 4209	# 110	# 119	# 3585	# 69
Seq. Current Liabilities Change	4.87 %	-1.38 %	5146.69 %	-96.43 %	-5.5 %
Seq. Cash & cash equivalent Change	-21.84 %	57.78 %	-49.02 %	10.72 %	-70.12 %

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 437
Healthcare Sector	# 886
Overall Market	# 4209

Quick Ratio Statistics
High	Average	Low
15.94	2.26	0
(Nov 30 2018)		(Nov 30 2025)

Financial Statements
Cnbx Pharmaceuticals Inc 's Current Liabilities	$ 3 Millions	Visit CNBK's Balance sheet
Cnbx Pharmaceuticals Inc 's Cash & cash equivalent	$ 0 Millions	Visit CNBK's Balance sheet
Source of CNBK's Sales		Visit CNBK's Sales by Geography

Cumulative Cnbx Pharmaceuticals Inc 's Quick Ratio

CNBK's Quick Ratio for the trailling 12 Months

CNBK Quick Ratio	(May 31 2026) 12 Months	(Feb 28 2026) 12 Months	(Nov 30 2025) 12 Months	(Aug 31 2025) 12 Months	(May 31 2025) 12 Months
Y / Y Current Liabilities TTM Growth	41.28 %	15.92 %	-4.32 %	-27.63 %	-11.01 %
Y / Y Cash & cash equivalent TTM Growth	-56.86 %	-70.14 %	-46.77 %	-58.02 %	-67.98 %
Quick Ratio TTM	0.01	0.01	0.01	0.02	0.02
Total Ranking TTM	# 4013	# 96	# 113	# 3026	# 62
Seq. Current Liabilities TTM Growth	19.67 %	19.84 %	28.18 %	-23.15 %	-1.81 %
Seq. Cash & cash equivalent TTM Growth	-8.53 %	-40.81 %	-10.5 %	-10.97 %	-36.7 %

Quick ratio ranking by company, industry and sector >> Back to CNBK Financial Strength Comparisons >> Go to Compare CNBK Quick Ratio to its Competitors

On the trailing twelve months basis In Spite of the rise in Current Liabilities in the Q3 2026 to $2.67 millions, cumulative Quick Ratio remained unchanged at 0.01 below the Cnbx Pharmaceuticals Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 438 other companies have achieved higher Quick Ratio than Cnbx Pharmaceuticals Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 96 to 4013.

Explain Quick Ratio?
How much Cash & cash equivalents CNBK�s has?
What are CNBK�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	# 439
Healthcare Sector	# 896
Within the Market	# 4013

trailing twelve months Quick Ratio Statistics
High	Average	Low
13.3	2.47	0
(Aug 31 2019)		(May 31 2026)

Companies with similar Quick Ratio in the quarter ending May 31 2026, within Major Pharmaceutical Preparations Industry	Quick Ratio	May 31 2026 MRQ Cash & cash equivalent	May 31 2026 MRQ Current Liabilities
The Greater Cannabis Company Inc	0.01	$ 0.000 Millions	$ 0.012 Millions
Chemocentryx Inc.	0.01	$ 1.253 Millions	$ 139.868 Millions
NIKA PHARMACEUTICALS, INC	0.01	$ 0.003 Millions	$ 0.341 Millions
Evofem Biosciences Inc	0.01	$ 0.714 Millions	$ 88.615 Millions
Rain Enhancement Technologies Holdco Inc	0.01	$ 0.071 Millions	$ 13.574 Millions
IMPACT BIOMEDICAL INC.	0.00	$ 0.010 Millions	$ 2.045 Millions
Semnur Pharmaceuticals Inc	0.00	$ 0.039 Millions	$ 10.672 Millions
Cnbx Pharmaceuticals Inc	0.00	$ 0.010 Millions	$ 2.673 Millions
Accustem Sciences Inc	0.00	$ 0.013 Millions	$ 5.724 Millions
Skinvisible Inc	0.00	$ 0.004 Millions	$ 5.174 Millions

Date modified: 2026-07-01T13:22:21+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.